Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Methylfolate wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
7 of 9 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Methylfolate and Riboflavin have evidence — compare verdict strength side-by-side.
400-800mcg daily
Morning with or without food, Consistent daily timing
L-Methylfolate (5-MTHF)
25-50mg for general health; 400mg for migraine prevention
With food for better absorption, Morning with other B vitamins
Riboflavin or Riboflavin-5-Phosphate (R-5-P)
2-4 weeks
1-3 weeks
4-8 weeks
Days to weeks
3 months
2-4 weeks
Immediate
Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials
Nutritional neuroscience (2023) · Systematic review · n=2256
Systematic review examining Methylfolate efficacy
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders
Pharmacopsychiatry (2022) · Meta analysis · n=6707
In the meta-analysis of categorical Hamilton Rating Scale for Depression-17 response, (three studies, N=483) adjunctive L-methylfolate was associated with a small effect versus antidepressant monotherapy (relative risk: 1.25, 95% confidence interval [CI]=1.08 to 1.46, p=0.004).
Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis
Psychopharmacology (2018) · Meta analysis · n=925
Pooled FA + AP treatments were more effective than placebo + AP for negative symptoms (N = 5, n = 281; SMD = -0.25, 95% CI = -0.49, -0.01, p = 0.04, I2 = 0%).
Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis
Nutritional neuroscience (2022) · Meta analysis · n=673
Vitamin B2 supplementation significantly decreased migraine days (p = .005, I2 = 89%), duration (p = .003, I2 = 0), frequency (p = .001, I2 = 65%), and pain score (p = .015, I2 = 84%).
Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025) · Meta analysis
In adults, compared with placebo, these supplements did not significantly affect other outcomes, and omega-3 supplementation did not yield a statistically significant reduction in any of these outcomes.
Riboflavin supplements for blood pressure lowering in adults
The Cochrane database of systematic reviews (2025) · Meta analysis · n=320
The evidence for the effect of oral riboflavin supplements on systolic and diastolic blood pressure is very uncertain.
Based on meta-analysis showing small effect size for adjunctive L-methylfolate. RCT showed efficacy at high doses but effectiveness appears modest. Risk increases with higher doses due to overmethylation symptoms.
Based on meta-analysis showing significant reduction in migraine frequency, days, duration, and pain score. High heterogeneity (I2=65-89%) in pooled analyses suggests variable individual responses. Most studies used 400mg daily dose.
AI-estimated from published studies. Interpret as directional guidance.
Methylfolate has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For prenatal support, Methylfolate has a higher relevance score (95 vs 78).
No known interactions between Methylfolate and Riboflavin have been documented in our database. However, always consult a healthcare provider before combining supplements.